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Abstract
Symbiotic associations between eukaryotes and microorganisms are frequently observed in nature, and range along the continuum between
parasitism and mutualism. The genus Wolbachia contains well-known intracellular bacteria of arthropods that induce several reproductive
phenotypes that beneﬁt the transmission of the bacteria. Interestingly, Wolbachia bacteria have been found in the Onchocercidae, a family of
ﬁlarial nematodes, including species that cause human ﬁlarial diseases, e.g. lymphatic ﬁlariasis and onchocerciasis. The endosymbiont is
thought to be mutualistic in the Onchocercidae, and to provide essential metabolites to the ﬁlariae. Currently, Wolbachia bacteria are
targets of antibiotic therapy with tetracyclines, which have profound effects on the development, viability and fertility of ﬁlarial parasites.
This overview article presents the Onchocercidae and Wolbachia, and then discusses the origin and the nature of the symbiosis. It highlights
the contribution of Wolbachia to the survival of the ﬁlariae and to the development of pathology. Finally, the infection control implications
for ﬁlariases are debated. Potential directions for future research are also discussed.
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Introduction
Among the Nematoda, the order Spirurida encompasses the
familyOnchocercidae, commonly knownas ﬁlariae. They infect a
broad range of terrestrial vertebrates, and many of them are
responsible for medical and veterinary issues in mammals
(Table 1) [1–27]. They are all transmitted by haematophagous
arthropod vectors that are either pool-feeders (telmophagous)
(e.g. black ﬂies for onchocerciasis transmission, or tabanid ﬂies
for loasis) or vessel-feeders (solenophagous) (e.g. mosquitoes
for lymphatic ﬁlariasis transmission, or ticks for canid ﬁlariasis)
(Table 1). Filarial nematode species can hostWolbachia bacterial
endosymbionts. Research on the symbiosis of Wolbachia and
Onchocercidae has highlighted the contributions of bacteria to
the reproduction of ﬁlariae, the inﬂammatory disease patho-
genesis, and the immunomodulation of the vertebrate host, and
has led to the consideration of antibiotic therapy as a novel
method of treatment.
Biology of Filariae and their Endosymbiont
Wolbachia
The microﬁlariae (stage 1 or L1) are taken up by the vector
during a blood meal. In this intermediate host, they moult and
develop until they become stage 3 (infective) larvae (L3).
Throughout this development, the larvae migrate from the
ingested blood to other tissues, depending on the vector
species [28]. During another blood meal of the vector, the
infective larvae are passed to the dermis of the vertebrate’s
skin. Once there, the L3 larvae moult into stage 4 larvae within
2 days for the genera Onchocerca and Diroﬁlaria, and within
approximately 10 days for the other genera [28]. Most of the
species migrate through the host’s body from the skin to their
deﬁnitive niche, mainly the lymphatic system, the coelomic
cavities, the cardiopulmonary system, and connective tissues
(Table 1). The fourth and ﬁnal moult results in adult male or
female worms.
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Filarial diseases are often asymptomatic in wild fauna.
Clinical manifestations and pathologies can depend on the
tissue localization of microﬁlariae or adult worms, the parasite
burden, and the vertebrate host’s immune response. In
endemic zones, one in six people are affected by human
ﬁlariases, representing an estimated 150–180 million infested
people, of whom 37 million harbour Onchocerca volvulus, the
agent of onchocerciasis, also known as ‘river blindness’. The
latter pathology is responsible for many ocular and cutaneous
lesions: chronic onchocercal dermatitis with pruritus, cutane-
ous licheniﬁcation, and depigmentation of the skin (‘leopard
skin’). In addition, subcutaneous nodules are formed around
female worms. Similarly, Onchocerca ochengi females induce the
formation of a nodule in the dermis of the bovine host, in
which they remain sedentary and in close association with the
host’s tissue. Lymphatic ﬁlariasis is caused by Wuchereria
bancrofti and Brugia spp. It is the second largest cause of long-
term disability, with one-third of patients suffering from clinical
presentations of the infection, namely lymphoedema of the
extremities (elephantiasis) and hydrocoele. Many ﬁlariases
have also been described in domestic dogs, the best known
being the ‘heartworm disease’ caused by Diroﬁlaria immitis. Live
heartworms can cause endarteritis and muscular hypertrophy
of arteriole walls, especially in the caudal pulmonary arteries. If
left untreated, these alterations lead to pulmonary hyperten-
sion and right-sided congestive heart failure [22,29]. In horses,
ﬁlarial infections can be caused by various agents, one of them
being Setaria equina; this is a rather asymptomatic ﬁlariasis,
although it is potentially responsible for ocular lesions [27].
Many cases of zoonoses caused by mammalian ﬁlariae belong-
ing to the two subfamilies Onchocercinae and Diroﬁlariinae
have been identiﬁed [30]. Two rare zoonoses have also been
described: one caused by Meningonema peruzzii, from the
subfamily Splendidoﬁlariinae [31], and another caused by
Pelicitus sp., an avian ﬁlaria [32].
Many ﬁlariae harbour Wolbachia, a Gram-negative intracel-
lular a-proteobacterium (order Rickettsiales). Up to now,
Wolbachia bacteria have been identiﬁed in two of the eight
subfamilies of Onchocercidae, namely the Onchocercinae and
the Diroﬁlariinae (Fig. 1) [33,34]. Among them, Wolbachia
bacteria are present in all human ﬁlariae except Loa loa [35],
and have not yet been analysed in Mansonella streptocerca
(Table 1). Wolbachia bacteria are vertically transmitted to the
ﬁlarial progeny through the female germline. They contaminate
numerous classes of arthropods (40% of terrestrial arthropod
species are infected [36]), but only a single family of
nematodes, the Onchocercidae [37]. Wolbachia bacteria have
not been detected in any other nematode groups [38,39],
although their presence in Radopholus similis, a plant-parasitic
nematode, has been suggested [40]. Wolbachia bacteria are
commonly classiﬁed in different supergroups, although they
are attributed to one species, namely Wolbachia pipientis.
These supergroups show an asymmetric distribution within a
large host range: supergroups A, B, E, H, I and K are found in
arthropods; and supergroups C, D and J are limited to ﬁlariae.
Interestingly, supergroup F encompasses both arthropod and
ﬁlarial hosts [37,41–44].
The Evolutionary History of the Symbiosis
and the Basis of Mutualism
Until recently, it was hypothesized that Wolbachia infection
may have been acquired as a single event in the Onchocercidae
[34,45], and that there was a congruency between the
phylogenies of Wolbachia and the ﬁlarial host [45]. Analyses
of new onchocercid species have challenged these features,
and the relationships between Onchocercidae and Wolbachia
appear to be more complex. The presence of Wolbachia in
Onchocercidae has been overestimated: from 89.5% in 2003
[39], more extensive analyses have led this estimate to be
reduced to 37% [37]. The absence of Wolbachia in these
Onchocercidae could be linked to two types of evolutionary
event. First, the absence of Wolbachia is likely to be an
ancestral condition [33,34,37]. Indeed, the morphologically
primitive Onchocercidae, such as the Waltonellinae and
Oswaldoﬁlariinae subfamilies, have no Wolbachia (Fig. 1). This
suggests that these ﬁlariae diversiﬁed before the ﬁrst Wolba-
chia infection in the Onchocercidae lineage. Second, it was
recently shown that an unexpectedly high number of second-
ary losses occurred in Diroﬁlariinae and Onchocercinae.
These losses are supported by the identiﬁcation of Wolbachi-
a-like gene sequences in ﬁlarial host genomes of species that
do not harbour Wolbachia, such as Onchocerca ﬂexuosa and
Acanthocheilonema viteae [46].
The hypothesis of acquisition by a single event seems to be
contradicted by the identiﬁcation of supergroup F. Indeed, the
existence of this supergroup, which includes Wolbachia from
both arthropods and nematodes, reveals that another acqui-
sition event has happened more recently and independently
from the one leading to supergroups C and D [37,41].
Up to now, the nature of the symbiosis between Wolbachia
and Onchocercidae has been considered to be mutualistic, as
both partners seem to beneﬁt from the association [47].
Indeed, many studies have investigated the effects of antibiotic
chemotherapy on various Onchocercid species, and have
demonstrated that depletion of Wolbachia is associated with
stunting, sterilization and death of adult worms [8,48,49]. The
evidence for mutualism was strengthened by the analysis of the
complete genomes of the Wolbachia strain from the human
ª2012 The Authors
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lymphatic ﬁlaria Brugia malayi [50] and the bovine tissular ﬁlaria
O. ochengi [51]. This revealed that the genome of Wolbachia
carries the genes required for haem metabolism and/or
riboﬂavin, whereas its ﬁlarial host does not [50–52]. An
interaction between Wolbachia and the host’s iron metabolism
has been recently demonstrated in a parasitoid wasp [53]. Thus,
one can argue that Wolbachia could help ﬁlarial nematodes to
acquire and keep iron, as observed in arthropods. However,
how transport, degradation and regulation of haem occurs
within ﬁlarial parasites remains an open question [54].
In ﬁlariae, Wolbachia bacteria are present in all larval stages,
although their density varies between individual worms
and throughout the developmental stages [55,56]. Usually,
Wolbachia bacteria are localized in the hypodermal cells of the
lateral cords in ﬁlariae [57,58].Wolbachia bacteria are also found
in the ovaries, in the oocytes, and throughout embryonic
development in the uterus of females. However, they are never
found in the male reproductive system [59,60]. It was recently
shown that Wolbachia bacteria of supergroups C and D follow
the same pattern of embryonic segregation: through asymmetric
mitotic segregation, they reach a subset of hypodermal cells [57].
From this hypodermic localization,Wolbachia bacteria then have
to invade the ovaries [59,61]. However, the tissue distribution of
Wolbachia bacteria in ﬁlariae can bemore complex: for example,
a supergroup F Wolbachia bacterium has been detected in the
intestinal cells but not in the hypodermis of Mansonella
(Cutiﬁlaria) perforata [37]. Consequently, this pattern of tissue
localization raises the issue of different bacterial segregation
during embryogenesis, reﬂecting different tropisms of the
bacteria in their hosts. Furthermore, a nutritional beneﬁt of
supergroup F Wolbachia for the host has been documented in
the bedbug Cimex lectularius, wherein the antibiotic depletion of
FIG. 1. The presence of Wolbachia infection mapped on the hypothetical evolution and distribution of Onchocercidae. The eight subfamilies of
Onchocercidae are represented on the ‘pie chart’; the sector size of each subfamily is based on the number of onchocercid genera present per
subfamily. The host range is shown by a symbol: the crocodile represents clade Reptilia, the frog represents class Amphibia, the bird represents class
Aves, and the monkey represents class Mammalia. For each subfamily, X/Y represents the number of genera in which the presence of Wolbachia was
analysed/the total number of genera in the subfamily. Underneath X/Y and below the black arrow, the number of genera that harbour Wolbachia
(Wb+) is speciﬁed. The dendrogram in the centre of the diagram represents the hypothetical evolutionary history of Onchocercidae, based on
morphological criteria. Wolbachia was absent from the lineages leading to Oswaldoﬁlariinae, Waltonellinae, Setariinae, and Splendidoﬁlariinae.
Wolbachia of supergoup C was acquired on the lineage leading to the Diroﬁlariinae. Wolbachia was acquired on the lineage leading to the
Onchocercinae, diverging into supergroups C, D, J, and F.
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the symbionts can be counteracted by oral supplementation
with B vitamins [62].
The role of Wolbachia in Filarial Biology and
Development of Pathology
From the entry of the parasite to the establishment of the
chronic disease, Wolbachia plays multiple roles, such as
exacerbating proinﬂammatory pathogenesis and immunomod-
ulation of the host, as well as enhancing survival of the ﬁlariae.
During the early phase of the infection, the inﬂammation
mediated by Wolbachia in the skin favours the vascular
migratory pattern of the Litomosoides sigmodontis infective
larvae and their subsequent establishment in the pleural cavity
of the murine host. For example, CCL17 is involved in the
early immune responses limiting ﬁlarial parasite invasion into
the host [63]. Indeed, genetic deﬁciency of CCL17 or
administration of anti-CCL17 antibodies results in mast cell
accumulation and degranulation, enhanced vascular permeabil-
ity, and increased ﬁlarial load. This mechanism is dependent on
the presence of Wolbachia endosymbionts in infective L3 larvae
and is promoted by Toll-like receptor (TLR)2-dependent
signalling [63].
Wolbachia can trigger a proinﬂammatory response through
interaction with monocytes/macrophages, dendritic cells, and
neutrophils [64–66]. This role of Wolbachia can be replicated
in vitro by exposing innate immune cells to parasite extracts.
Indeed, antigen-presenting cells stimulated with whole Wolba-
chia-containing worm extracts release high quantities of
inﬂammatory cytokines, whereas stimulation with Wolbachia
antibiotic-depleted worm extracts or with extracts of Wolba-
chia-free ﬁlariae does not trigger such a response [67–69]. In
addition, various pathogen-associated molecular pattern can-
didates for Wolbachia have been shown to mediate the
inﬂammatory response, such as diacylated lipoproteins, which
drive the innate inﬂammatory response and Th1 polarization
[68], Wolbachia surface protein (which is a highly expressed
surface protein of Wolbachia), which triggers both inﬂamma-
tion and expression of regulatory markers such as cytotoxic T-
lymphocyte antigen 4 on T-cells [70], heat shock protein 60,
which induces inﬂammatory cytokine release by monocytes
and their subsequent apoptosis [71,72], and, potentially,
GroEL, even though this has not yet been formally proved
[51]. The recognition of Wolbachia pathogen-associated
molecular patterns has been shown to be dependent on
TLR2/TLR6 recognition and signalling [68,69] and, to a lesser
extent, on TLR1 recognition. Long-term exposure to Wolba-
chia proteins drives macrophage/monocyte tolerance both
in vitro and in vivo [67].
The role of Wolbachia in ﬁlarial biology may be seen as a
defensive mutualism. For example, the presence of Wolbachia
in O. ochengi contributes to the recruitment of a high level of
neutrophils in the vicinity of the ﬁlaria in the nodule [73]. In
contrast, after depletion of Wolbachia by antibiotic treatment,
eosinophils are recruited in the vicinity of O. ochengi and are
effective for ﬁlarial destruction [74–76]. If the treatment is
stopped, the recrudescence of Wolbachia can reconstitute the
neutrophilia. Wolbachia thus prevents the degranulation of
eosinophils by triggering an ineffective neutrophil response by
the host [73].
Increasingly, Wolbachia is being revealed as an important
cause of pathology in ﬁlarial diseases. Symptoms are correlated
with increases in the levels of circulating Wolbachia protein and
DNA, and with the detection of antibodies directed against the
endosymbiont [77–79]. Such an increase in the detection of
Wolbachia in blood of patients may be attributable, in part, to
the natural excretion of Wolbachia products by the worms, or
the moribund microﬁlariae or adults that release Wolbachia
[61,66,80].
Most of the pathology observed in ﬁlariases results from the
inﬂammatory response. In onchocerciasis, the main pathology
is caused by the migration of microﬁlariae to the cornea,
where the inﬂammatory response leads to corneal inﬂamma-
tion of variable severity. This pathology is neutrophil-mediated
through Wolbachia TLR2 activation of macrophages and local
stromal cells. These cells produce proinﬂammatory cytokines
and CXC chemokines, which mediate neutrophil recruitment
[81,82]. In chronically infected individuals, the repeated
invasion of microﬁlariae and their subsequent death perpet-
uates the inﬂammatory cell inﬂux, which causes permanent
tissue damage, owing to neutrophil degranulation and secre-
tion of cytotoxic products such as nitric oxide, myeloperox-
idase, and oxygen radicals [83].
In lymphatic ﬁlariasis, the presence of elevated levels of
lymphangiogenic factors has been shown to be associated with
the severity of the pathology [84,85]. As TLR2 stimulation by
extracts of B. malayi has been shown to trigger vascular
endothelial growth factor A and angiopoietin-1 production
[86], it is possible that Wolbachia is involved in the pathogen-
esis. This role has been indirectly conﬁrmed by Wolbachia
depletion with doxycycline treatment in Bancroftian patients,
in whom a reduction in the dilatation of the scrotal lymph
vessels was observed [87].
Wolbachia as a Filaricidal Target
Currentmassdrugadministrationprogrammesdesigned tocontrol
and eliminate ﬁlariasis support the use of diethylcarbamazine or
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ivermectin, each given in combination or notwith albendazole [88].
These agents are potent microﬁlaricides, but have limited macro-
ﬁlaricidal effects. As adult ﬁlariae are long-lived and fecund formost
of their lifetime, patients must be treated for many years for there
to be any chance of breaking the transmission cycle [89].
Furthermore, several researchers are raising concerns about the
possible development of resistance in the worms [90,91]. In some
onchocercian communities, even after several roundsof ivermectin
treatment, the average microﬁladermia increases instead of
decreasing as expected. In the area of mass therapy, both for
lymphatic ﬁlariasis and for onchocerciasis, children often present
with microﬁlariae in the blood or skin, thus indicating that the
transmission is still ongoing. All in all, the need for a new therapeutic
approach against ﬁlariasis has emerged.
For the last decade, therapeutic research has focused on the
value of Wolbachia as a ﬁlaricidal target. First, the use of
antibiotics (tetracycline class) against onchocerciasis in vitro
and with animal models has been shown to block transmission
by disrupting embryogenesis [92–94]. This sterilization results
from Wolbachia depletion, as antibiotic treatment of ﬁlariae
free of Wolbachia has no inﬂuence on embryogenesis or
viability of the parasite [66]. Recently, it has been demon-
strated that this depletion induces the apoptosis of both the
germinal line and the somatic cells in the embryos and in the
microﬁlariae [95].
Anti-Wolbachia therapy with doxycycline (a semisynthetic
derivative of the tetracycline family) has been recommended
for the treatment of individuals with lymphatic ﬁlariasis and
onchocerciasis [8,48,58,84,85,95–102] (Table 2). It allows the
development of ﬁlariae in their vector to be blocked, thus
arresting the transmission [103,104]. Furthermore, macroﬁl-
aricidal effects against onchocerciasis have been reported in
humans 2 years after treatment [97,105]. Community-
directed treatment has been undertaken and been successful
[106,107], although mass treatment may still be a long way
off. Moreover, the use of antibiotics in areas of co-
endemicity with L. loa (Wolbachia-free) is safe, and does not
reduce the overall efﬁcacy of the treatment [105]. However,
doxycycline requires a prolonged treatment regimen (4–
6 weeks), and is contraindicated for children under 9 years
old and for pregnant/breast-feeding women. No other
tetracycline has been used in humans, because doxycycline
is the easiest to apply to humans with regard to safety and
side effects. However, the most used tetracycline in animals
such as cattle is oxytetracycline [73,108]. In addition,
rifampicin could be used as an alternative treatment for
cases that cannot be treated with doxycycline. Indeed, it was
shown that 4 weeks of rifampicin treatment can reduce
ﬁlarial embryogenesis [109]; however, 1 week of treatment
was not efﬁcient [110].
Comparative genomic/transcriptomic/proteomic analyses of
ﬁlarial species associated or not with Wolbachia, and before
and after Wolbachia depletion, have pushed forward our
knowledge of the molecular/metabolic basis of the mutualism
between Wolbachia and its host, ultimately resulting in the
discovery of new drug targets [52,54,111–115]. Several new
approaches directed against Wolbachia are currently under
investigation (Table 2) [94,109,116–122]. One of the more
promising of these is corallopyronin A, a non-competitive
inhibitor of the RNA polymerase of Wolbachia [117]. The
blockade of RNA transcription gives rise to bacterial death and
thus to Wolbachia depletion in Litomosoides sigmodontis.
TABLE 2. Old and new therapies against Wolbachia
Drugs Target Mechanisms Effects on ﬁlariae References
Current antibiotic treatment
Doxycycline/
tetracycline
30S ribosomal
subunit (+50S
ribosomal subunit)
1. Blockade of protein synthesis
by preventing the binding of
aminoacyl-tRNA to the ribosome
(a) Decrease in ﬁlaria growth.
(b) In vitro female sterilization;
(c) Disappearance of Mfs
(d) Blockage of ﬁrst and third moults.
(d) Death of adult worms
[8,48,49,58,73,84,85,95,97–102,104,122]
2. Activation of apoptosis of germline
and somatic cells of embryos
and microﬁlariae
3. Nitric oxide production
New anti-Wb approaches
Berberin FtsZ Blockade of bacterial cytokinesis In vitro sterilization of Brugia malayi female [116]
In vitro decrease in Wb growth in B. malayi
Corallopyronin A RNA polymerase Blockade of RNA synthesis In vivo sterilization of Litomosoides
sigmodontis female
[117]
Decrease in Litomosoides sigmodontis growth
Succinyl acetone ALAD Blockade of haem pathway (a) Reduction in motility. (b) Sterility [54]
Rapamycin bTOR Inhibition of bTOR, which
controls autophagy
In vitro decrease in Wb growth in B. malayi [119]
Globomycin LspA Accumulation of pro-lipoprotein
in the cytoplasmic membrane
In vitro decrease of Wb growth in B. malayi [120]
In vitro reduction in motility of B. malayi
Rifampicine Inhibition of RNA polymerase (a) Abnormal and decreased embryogenesis [94,105,110]
(b) Reduction of the L3 to L4 moult
(C) Decrease in worm growth
ALAD, 5′-aminolevulinic acid dehydratase; bTOR, B. malayi target of rapamycin; FtsZ, ﬁlamenting temperature-sensitive protein Z; LspA, lipoprotein signal peptidase II; Wb,
Wolbachia.
The target of doxycycline is mainly the bacterial 30S ribosomal subunit and, to a lesser extent, the 50S subunit.
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The size of the ﬁlariae was reduced and embryogenesis was
stunted, without consequences for mice. The mean level of
endobacteria after treatment was even lower than the
reference standard obtained with doxycycline treatment. The
cytokinesis, polymerase and metabolic pathways of the bacte-
ria have been targeted in vitro in different ﬁlariae. For example,
ﬁlamenting temperature-sensitive protein Z, which is involved
in bacterial cytokinesis, can be blocked by berberin treatment.
Filamenting temperature-sensitive protein Z is expressed in all
stages of B. malayi. This blockade interrupts bacterial division,
and therefore growth of the bacterial population. Without
bacterial proliferation, embryogenesis of the ﬁlaria is
interrupted, and microﬁlarial release is decreased [116].
However, these new approaches have yet to be tested in
humans.
Conclusion
Over the last decade, ﬁlarial research has been conducted on
the assumption that the symbiotic relationship between
Wolbachia and ﬁlariae could offer opportunities to control
ﬁlariases. Antibiotic therapies against Wolbachia now provide a
valuable means of clinical control by reducing bacteria-induced
inﬂammation, an effective prevention strategy by breaking the
parasitic cycle (e.g. reducing microﬁlarial production, and
preventing their development in their vectors), and a way to
eliminate already-established parasites (i.e. by a macroﬁlaricidal
effect). Reﬁnement of the target and/or tools used against the
bacteria is already in progress, helped by the recent advances
in ‘omics’ technologies.
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